Your browser doesn't support javascript.
loading
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine.
Dominelli, Federica; Zingaropoli, Maria Antonella; Tartaglia, Matteo; Tortellini, Eeva; Guardiani, Mariasilvia; Perri, Valentina; Pasculli, Patrizia; Ciccone, Federica; Malimpensa, Leonardo; Baione, Viola; Napoli, Anna; Gaeta, Aurelia; Lichtner, Miriam; Conte, Antonella; Mastroianni, Claudio Maria; Ciardi, Maria Rosa.
Afiliación
  • Dominelli F; Department of Public Health and Infectious diseases, Sapienza, University of Rome, Rome, Italy.
  • Zingaropoli MA; Department of Public Health and Infectious diseases, Sapienza, University of Rome, Rome, Italy.
  • Tartaglia M; Department of Human Neurosciences, Multiple Sclerosis Centre, Sapienza, University of Rome, Rome, Italy.
  • Tortellini E; Department of Public Health and Infectious diseases, Sapienza, University of Rome, Rome, Italy.
  • Guardiani M; Department of Public Health and Infectious diseases, Sapienza, University of Rome, Rome, Italy.
  • Perri V; Department of Public Health and Infectious diseases, Sapienza, University of Rome, Rome, Italy.
  • Pasculli P; Department of Public Health and Infectious diseases, Sapienza, University of Rome, Rome, Italy.
  • Ciccone F; Department of Public Health and Infectious diseases, Sapienza, University of Rome, Rome, Italy.
  • Malimpensa L; Department of Human Neurosciences, Multiple Sclerosis Centre, Sapienza, University of Rome, Rome, Italy.
  • Baione V; Department of Human Neurosciences, Multiple Sclerosis Centre, Sapienza, University of Rome, Rome, Italy.
  • Napoli A; Department of Molecular medicine, Sapienza, University of Rome, Rome, Italy.
  • Gaeta A; Department of Public Health and Infectious diseases, Sapienza, University of Rome, Rome, Italy.
  • Lichtner M; Infectious Diseases Unit, Santa Maria Goretti Hospital, Sapienza, University of Rome, Latina, Italy.
  • Conte A; Department of Neurosciences Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.
  • Mastroianni CM; Department of Human Neurosciences, Multiple Sclerosis Centre, Sapienza, University of Rome, Rome, Italy.
  • Ciardi MR; Scientific Hospitalization and Treatment Institute, Neuromed Mediterranean Neurological Institute, Pozzilli, Italy.
Front Immunol ; 13: 1050183, 2022.
Article en En | MEDLINE | ID: mdl-36532061
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Italia